Skip to main navigation Skip to search Skip to main content

Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy

  • S. R. Martini
  • , M. D. Hill
  • , A. V. Alexandrov
  • , C. A. Molina
  • , T. A. Kent*
  • *Corresponding author for this work
  • Baylor College of Medicine
  • University of Calgary
  • University of Texas Health Science Center at Houston
  • St. Joseph's Hospital and Medical Center, Phoenix
  • Vall d'Hebron Hospital Universitari

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Hyperglycemia independently predicts poor outcome after acute ischemic stroke. CLOTBUST (Combined Lysis Of Thrombus in Brain ischemia using transcranial Ultrasound and Systemic tPA) demonstrated that ultrasound-augmented thrombolysis improves recanalization and 24-hour outcome in patients with acute ischemic stroke. We hypothesized that ultrasound would preferentially benefit hyperglycemic patients, and reviewed CLOTBUST with respect to admission glucose and good outcome. We found that ultrasound's benefit on 90-day outcome was primarily apparent at higher glucose levels, suggesting that ultrasound therapy may improve outcome following hyperglycemic stroke.

Original languageEnglish
Pages (from-to)700-702
Number of pages3
JournalNeurology
Volume67
Issue number4
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Outcome in hyperglycemic stroke with ultrasound-augmented thrombolytic therapy'. Together they form a unique fingerprint.

Cite this